Dhruv Shah
☆    

India,
2015-09-28 13:08
(3130 d 02:49 ago)

Posting: # 15476
Views: 5,018
 

 RSABE: Statistics & Regulatory requirements [RSABE / ABEL]

I just want to know that for RSABE study in addition to having a point estimate in between 80-125, do we need to calculate the 90% CI limits as we do in ABE study? (Is there a regulatory requirement?)
Moreover in order to establish BE, the 95% upper confidence bound must be less than or equal to 0. How it is calculated based on the BE outcomes and in simple term what does it mean? i.e what it means if the value is less than or equal to 0 and greater than 0.

Regards,
Dhruv Shah
jag009
★★★

NJ,
2015-10-01 15:57
(3127 d 00:00 ago)

@ Dhruv Shah
Posting: # 15510
Views: 3,575
 

 RSABE: Statistics & Regulatory requirements

❝ I just want to know that for RSABE study in addition to having a point estimate in between 80-125, do we need to calculate the 90% CI limits as we do in ABE study? (Is there a regulatory requirement?)


Please re-read the guidance.

John
d_labes
★★★

Berlin, Germany,
2015-10-01 18:23
(3126 d 21:34 ago)

@ Dhruv Shah
Posting: # 15511
Views: 3,669
 

 RSABE: Statistics & Regulatory requirements

Dear Druv,

additionally to John's suggestion I recommend you Helmut's lectures. There is one with special focus to RSABE / scaled ABEL.


Edit: F.i. Reference-Scaled Average Bioequi­valence (HVDs/​HVDPs), Mumbai, January 2013. [Helmut]

Regards,

Detlew
UA Flag
Activity
 Admin contact
22,991 posts in 4,827 threads, 1,647 registered users;
60 visitors (1 registered, 59 guests [including 7 identified bots]).
Forum time: 15:57 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5